BioNexus Gene Lab Corp - BGLC
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| HRT FINANCIAL LP | History | Closed out | 0 | 0 | — | 0.0% | — | -14,283 | -100.0% | Q3 2026 | Nov 13, 2026 |
| UBS Group AG | History | Added to | 306 | 0 | — | — | — | +205 | 202.97% | Q3 2026 | Nov 10, 2026 |
| Caitong International Asset Management Co., Ltd | History | Added to | 137 | 0 | — | — | — | +136 | 13600.0% | Q3 2026 | Oct 29, 2026 |
| Tower Research Capital LLC (TRC) | History | New | 12 | 0 | — | — | — | +12 | New | Q3 2026 | Nov 16, 2026 |
| JPMORGAN CHASE & CO | History | New | 2 | 0 | — | — | — | +2 | New | Q3 2026 | Nov 12, 2026 |